Principles of Psychopharmacology for Mental Health ProfessionalsPrinciples of Psychopharmacology for Mental Health Professionals addresses the current "split" model of mental health care, in which physicians provide pharmaco-therapy while non-prescribing practitioners oversee other services such as psychotherapy. Bringing these two areas together, this book familiarizes mental health professionals with the medications used to treat psychiatric disorders. Prepared by world-renowned psychopharmacologists and psychiatrists, this useful resource helps non-prescribing practitioners understand when and why a given medication is appropriate to use, when it is not indicated, and what potential side effects may occur. Also discussed are the appropriate times in therapy when a referral for a medication evaluation is indicated as well as how to broach this issue with the patient. Recognizing that there are almost always a number of medications from which to choose, the authors combine research outcomes with their extensive clinical experience to highlight the important considerations in selecting one medication over another. As an educational tool, the text encourages and supports clinicians who wish to increase patients' understanding of treatment. After an introduction and overview, chapters cover: * Basics of psychopharmacology * Attention-deficit hyperactivity disorder * Mood disorders * Sleep disorders * Schizophrenia * Cognitive disorders * Anxiety disorders * Personality disorders * Substance use disorders * Traumatic brain injury * Eating disorders * Side effects Every chapter includes diagnostic considerations, history of medication treatments, and emerging trends for each disease. Principles of Psychopharmacology for Mental Health Professionals lays out what psychotherapists and other mental health practitioners need to know about psychotropic medications, giving them and their patients an invaluable guide to the full array of treatments available. |
Contents
| 1 | |
| 9 | |
3 MOOD DISORDERS | 37 |
4 SCHIZOPHRENIA | 97 |
5 ANXIETY DISORDERS | 127 |
6 SUBSTANCE USE DISORDERS | 177 |
7 EATING DISORDERS | 207 |
8 ATTENTION DEFICITHYPERACTIVITY DISORDER | 231 |
Other editions - View all
Common terms and phrases
activity acute addition ADHD agitation alcohol Alzheimer’s disease anticholinergic anticonvulsants antidepressants Approach to Treatment atypical antipsychotics behavior benzodiazepines bipolar disorder blocking BPAD brain bupropion buspirone carbamazepine cause clinical clonazepam clonidine clozapine Cluster cocaine comorbid delirium dementia Diagnostic Criteria Differential Diagnosis dopamine drowsiness drug DSM-IV eating disorders enzyme episodes Evaluation and Differential fluoxetine haloperidol helpful History of Pharmacological increased inhibitors Initial Evaluation insomnia interactions lithium liver long-term major depression mania manic MAOIs medical illness methylphenidate mg/day mirtazapine mood disorders mood stabilizer narcolepsy nerve cell neurotransmitter norepinephrine olanzapine onset opiate panic attacks panic disorder patients personality disorders Pharmacological Treatment pharmacotherapy phase potency antipsychotics potential problems psychosis psychotherapy psychotic PTSD receptor reuptake Risk Factors risperidone schizophrenia seizures serotonin side effects sleep social anxiety disorder SSRIs stimulants studies substance abuse substance use disorders symptoms syndrome TCAs therapeutic therapy tion tolerated trazodone treat typical antipsychotics usually valproate venlafaxine worsen